BridgeMD
LOWOX
EU CTIS ID: 2024-513117-12-00
What this study is testing
To investigate if there is an improvement in postoperative arterial oxygen partial pressure (PaO2) after goal-directed low oxygen concentration during anesthesia compared to the routine use with fixed oxygen concentrations.
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adults (> 18 years old)
- The subject has given their written consent to participate in the trial.
- Be scheduled for abdominal surgery performed at the Departments of Surgery, Urology and Gynecology lasting more than 2 hours.
- Fall under the American Society of Anesthesia (ASA) Class 1-3.
You likely can't join if
- Increased risk for difficult intubation during anesthesia (Mallampati score 3-4) or previous documentation of difficult intubation.
- The inability to understand written or verbal information, thereby hindering the ability to provide informed consent.
- Obese with a BMI >35 kg/m2.
- Participation or recent participation within 30 days in a clinical trial with an investigational medicinal product. Previous participation in this trial.
- Pregnancy
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.